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Introduction
Treatment of infections in the hospital poses some unique
issues in comparison with treatment of other equally sick
inpatients without infections. The diversity of potential
pathogens for a given infected site (e.g., pneumonia) and
the changing spectrum of antimicrobial susceptibilities are
variables generally not encountered with other diseases.
Infectious diseases may also have distinctly geographical and/
or travel-related aspects as shown by inhaled fungal infections
such as coccidioidosmycosis from the southwestern United
States or Ebola virus disease in West Africa. Communicable
diseases due to specific infectious agents (e.g., influenza virus,
methicillin-resistant Staphylococcus aureus (MRSA), extended
spectrum beta-lactamase-producing gram-negative rod bacteria
(ESBL-GNR’s), and many other examples) also pose challenges
in timely diagnosis, infection control, and patient-familycolleague education. In the case of Ebola virus, the presence
of only a few infected individuals in the United States in 2014
caused nationwide concern among healthcare workers and
the public. Clinicians, infection control staff and the hospitalbased microbiology laboratory all received many inquiries
about potential routes of transmission, diagnostic testing, and
personal protective strategies.
Antimicrobial therapies, while often remarkably effective, also
carry the potential for specific adverse events, some infectious.
These include Clostridium difficile enterocolitis or fungal
overgrowth when broad spectrum agents are used. The high
cost of some agents and serious potential organ toxicities are
additional limiting factors, especially in the absence of a firm
diagnosis. Finally, inappropriate utilization of antimicrobial
agents—including unnecessary use, selection of an overly broad
spectrum of activity, too long a course, and too high or too low
a dose—can drive increasing microbial resistance to these drugs
[1].
Having practiced infectious diseases in the hospital setting
for over 30 years, I have seen the changing role of the clinical
microbiology laboratory in patient management. More recently,
as director of an antimicrobial stewardship program [2] in a
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community teaching hospital, I have also seen firsthand some of
the pressures and resource limitations affecting our laboratory.
Everyone, it seems, is being asked to do more with less, and to
have it done by “yesterday.” Fortunately, my health system’s
clinical microbiology laboratory has had very experienced
leadership and many technicians have over a decade of
experience in the field. This helps the hospital and entire health
system run more smoothly in the face of some of the challenges
previously detailed. However, the need to function quickly and
efficiently will continue to be a priority and warrant careful
thought and planning in many areas [3, 4, 5].

Timeliness of testing and reporting
Hospitals are now becoming 24/7 operations as there is
steady pressure to reduce duration of hospitalization. I have
seen patients discharged after very short stays, though this is
sometimes at patient/family insistence rather than as a clinical
plan. However, every decision to discharge represents a balance
between having enough clinical information for diagnosis and
selecting effective therapy (e.g., an antibiotic) versus how sick
a patient is and the prognosis for improvement. Much of this
pressure is financial and clinicians have in many cases been able
to both shorten hospitalization and maintain quality of care.
Examples are higher dose shorter duration oral fluoroquinolone
regimens and overall shorter durations of intravenous therapy
for pneumonia than used in the past. These approaches
have safely reduced the percentage of pneumonia patients
requiring admission and facilitated earlier discharge of others.
Unfortunately, this trend has led to microbiology laboratory
test results sometimes becoming the rate-limiting step in the
discharge process. For example, consultants may be asked to
recommend oral therapy for discharge BEFORE pathogens
have been identified or susceptibilities determined. While
patients who have defervesced and whose signs and symptoms
of infection are resolving would seem to be good candidates
for discharge on oral antimicrobials, there are enough cases of
bacteria resistant to common oral agents of choice to make this
risky clinically and medicolegally.

ULJRI Vol 2, (1) 2018

7

The best approach from the microbiology bench would therefore
be to emphasize rapidity of turnaround time on gram stains,
cultures, and serologies WITHIN REASON. Rapid diagnostic
testing is one answer, as in the case of influenza A/B, respiratory
syncytial virus, and other pathogens for which a timely diagnosis
may open up outpatient management options and allow very
specific antimicrobial treatment or simply supportive care.
Streamlining specimen handling may be another approach.
My five-hospital health system utilizes a central microbiology
lab so that specimen transit time has to be considered for most
of the hospitals. Local specialized “stat lab” testing is one
response, depending on cost and efficiency studies. On the
other hand, investing in very expensive equipment to speed
identification of an organism or generate susceptibilities a few
hours earlier may not be the best investment. Review of the flow
of clinical specimens from collection to transport to processing
to reporting of results indicated getting final results at 3 am
rather than 6 am probably doesn’t improve efficiency very much.
Whatever the methods for getting results quickly, the clinical
benefit is considerably enhanced by interpreting them correctly
and communicating results effectively [6].

Insuring expertise in interpreting
results
Two of the trends cited previously also impact the usefulness of
data coming from the microbiology laboratory. One is the need
for prompt reporting of results to clinical services to facilitate
patient care. The other is the move to off-site laboratories as
groups of hospitals consolidate services to contain costs. The
days when clinicians dropped by the microbiology lab to chat
about a case or teams from clinical services routinely rounded
through the laboratory to exchange information are now less
common. Despite this, as laboratory testing becomes more
specialized and faster, the need to accurately interpret test
results is ever more important.
For example, a new generation of rapid diagnostic tests using
polymerase-chain assays or gene probes can yield results on
clinical microbiology specimens within hours [6]. However,
the results may be preliminary and/or incomplete as when a
specimen is reported as an ESBL-producer without specific
susceptibilities or as one of a group of similar pathogens
without definitive identification. Given the amount of medical
knowledge that health care providers must keep track of these
days, it is not surprising that few practitioners can stay current
on all the advantages and limitations of new microbiologic
diagnostic studies. The microbiology laboratory staff is therefore
increasingly responsible for getting the latest information to the
right personnel to act on it [7].
In many hospital systems, the availability of rapid diagnostic
testing has triggered a debate about when results should
be communicated and who should be responsible for the
subsequent decision-making. This includes automated results
becoming available in the middle of the night. In many cases
these can just be reported via the electronic health record for
interpretation at rounds in the morning. However, for some
potentially life-threatening or communicable infectious diseases
(e.g., bacteremias, positive CSF cultures, some sputum tests,
etc.) it has been argued that the information should be acted
on as soon as possible. The chain of reporting of “stat” results
may involve nursing, pharmacy, and emergency department/

infectious diseases/pulmonary/other consultants, as well as the
responsible primary service and microbiology laboratory staff.
Decisions may involve laboratory personnel explaining results
versus waiting for a supervisor in the morning. This is an issue
of laboratory training and policy [3]. When critical information
is communicated to hospital clinical staff for decision-making
such as selection or modification of an antibiotic regimen, who
must be involved? In most cases, the decision is easily made
by the primary service. However, late at night, especially when
coverage physicians not familiar with the case are involved or
the decision rests on incomplete pathogen identification or
antibiotic susceptibility results, who does the work? Current
approaches include programs to educate healthcare providers
about new diagnostic tests, antibiotic options, and when
to contact a specialist not currently involved in the case.
Unresolved issues are how to spread out the on-call burden and
whether there should be institutional compensation for this
additional call responsibility.

Communicating effectively
Further, great patient care relies on communication -- from
the patient and family to the diagnosing clinicians to the
treating staff and back again. Much information is now being
communicated online, e.g., the electronic health record (EHR)
and local viewing of radiographic data on personal computers.
Availability of data almost as quickly as it is generated is
certainly a great improvement over the old paper report slips
or once daily printouts of results [8]. However, someone must
look up the data in the EHR and for certain information such
as positive blood cultures or sputum acid-fast bacilli smears,
rapid and accurate reporting to someone in a position to act on
the results is critical. Thus, having experienced laboratory staff
that understand this and get the information to the appropriate
health care provider(s) can have a positive effect [8].
Even routine reports can provide guidance that improves
timeliness of patient care. A gram stain report on sputum can
provide much information to distinguish oral contamination
from true infection. Also, describing growth in “chains” versus
“clusters” for gram-positive cocci, especially in blood or other
usually sterile fluids, can get appropriate clinical management
going earlier. It goes without saying that this data has to be
generated by technicians confident in their readings and that
changes should be flagged, timed and dated. There have been
occasional inexperienced laboratory staff that have changed
readings as from gram-positive to gram-negative or from
culture-positive to -negative without leaving documentation
of the change. This can be very harmful to patient care and
clinician confidence in the laboratory. This leads to a related
topic. Clinicians need to have an understanding what a clinical
microbiology technician does (e.g., how many minutes’ search
does it take to declare a sputum acid-fast bacterial smear
negative) to best use their services. A microbiology lab staffer
needs to have an idea why a clinician wants to know ASAP if the
staphylococcus is coagulase-negative or –positive or whether the
gram-negative rod is a non-lactose fermenter and how it affects
clinical decision-making. Participation of laboratory personnel
and clinicians in rounds, conferences, or other activities to
discuss patient management should be encouraged, perhaps in
more formal settings if casual interactions are no longer feasible
due to distance, etc.
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Emphasize education
As a result of the previous considerations, everyone in health
care is (or should be) an educator. In the case of the clinical
microbiology laboratory, there is a very important role in
educating other hospital staff about microbiology findings [9].
In some cases, this is one-on-one over the telephone about
a specific patient’s data or in response to a general question
about how to interpret an antibiogram. When communicating
culture results, explaining current institutional pathogen
resistance profiles, or fielding a request for specialized testing,
the challenge is to communicate the answer clearly AND
GAUGE HOW WELL IT IS UNDERSTOOD [7]. Read back of
critical results is one way to insure the information was correctly
communicated and errors avoided. While laboratory staff in
academic teaching hospitals are probably used to hearing from
medical students not quite sure what they are asking about,
this is not an infrequent occurrence at any hospital. The classic
mistake seen by infectious diseases physicians is to be called
about “the best treatment” for an enterococcal infection. A little
research, which fortunately no longer necessitates a trip to the
patient’s chart or a call to the microbiology lab, reveals that the
organism is an Enterobacter species. The proliferation of health
care extenders (physicians’ assistants, nurse practitioners,
etc.) mean that staff in the microbiology laboratory should
be comfortable discussing the significance of a culture with
polymicrobial growth, multidrug-resistant pathogens (such as
ESBL-GNR’s), and coagulase-negative staphylococci versus
Staphylococcus aureus, with individuals of differing levels
of clinical expertise and experience. Knowing when to refer
questions to a laboratory supervisor or specialist service, is also
key. This is often the case in which as caller is asking about
the significance of microbiology results vis-à-vis isolation for
specific communicable diseases, management of patients with
unusual pathogens, or serologic testing for exotic diseases.
The further these questions fall outside of the microbiology
lab routine, the more an accurate referral (ideally with specific
contact information) will save time and angst for all concerned.

Think multidisciplinary; embrace
technology

and resistance trends. This may allow valuable epidemiologic
studies to guide future decision-making. Point of service
education is also becoming feasible, guiding practitioners
on antimicrobial costs, reasons for restrictions on specific
agents, and reporting requirements as they enter orders via the
computer. Publishing antibiograms regularly is also useful, as
much for infection control and formulary committee purposes,
as for guiding individual practitioners in antimicrobial selection.
While this can be a time-consuming task, software can be a
major help in the endeavor.
It has been argued that only death and taxes are certain, but
I suspect that increasingly rapid changes in the way everyone
manages data will be a common theme now and in the future.
Clinical microbiology information is key to treating many
patients in and out of the hospital, and getting the data to the
right groups in a timely fashion in as useful a form as possible
will be more and more critical. Current efforts support faster
and more specific diagnosis of infections, when not to use
antibiotics, earlier use of appropriate antimicrobials, and
narrowing and stopping therapy as soon as possible. If done
prudently, hopefully this will help control and reverse the trend
toward more resistant pathogens which have fewer options for
treatment [10].
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